24346 
Federal Register / Vol. 52, No. 125 / Tuesday. June 30, 1987 / Notices 
D. Miscellaneous 
1. Clonidine 
2. Methaqualone 
Clonidine is marketed in the United 
States as an antihypertensive agent. 
However, the substance is widely used 
in many other countries in the treatment 
of opiate and alcohol withdrawal 
syndrome. According to WHO, clonidine 
is abused in some countries and has 
appeared in illicit traffic. 
Methaqualone is a depressant 
controlled in schedule 1 of the CSA. The 
substance currently has no accepted 
medical use. In 1980, the CND 
rescheduled methaqualone from 
schedule IV to schedule II of the 
Psychotropic Convention. 
III. Opportunity to Submit Domestic 
Information 
As required by section 201(d)l2)(A) of 
the Controlled Substances Act (21 U.S.C. 
811(c)(2)(A)). FDA on behalf of HHS 
invites interested persons to submit data 
or comments regarding the above-named 
14 drugs. Data and information received 
in response to this notice will be used to 
prepare scientific and medical 
information on these drugs, with a 
particular focus on each drug’s abuse 
liability. HHS will forward that 
information to WHO, through the 
Secretary of State, for WHO's 
consideration in preparing a report for 
presentation to a WHO review group, 
which will evaluate the need for 
international control of these drugs. 
Such control could limit, among other 
things, the manufacture and distribution 
(import/export) of these drugs, and 
could impose certain recordkeeping 
requirements on them. 
HHS will not now make any 
recommendations to WHO regarding 
whether any of these drugs should be 
subjected to international controls. 
Instead, HHS will defer such 
consideration until WHO has made 
official recommendations to the 
Commission on Narcotic Drugs, which 
are expected to be made in the second 
half of 1988. Any HHS position 
regarding international control of these 
drugs will be preceded by another 
Federal Register notice soliciting public 
comment as required by 21 U.S.C. 
811(d)(2)(B). 
Interested persons may, on or before 
July 3, 1987, submit to the Dockets 
Management Branch (address above) 
written comments regarding this action. 
This abbreviated acceptance period is 
necessary to allow sufficient time to 
prepare and submit the domestic 
information package by the deadline 
imposed by WHO. 
Two copies of any comments are to be 
submitted, except that individuals may 
submit one copy. Comments are to be 
identified with the docket number found 
in brackets in the heading of this 
document. Received comments may be 
seen in the office above between 9 a.m. 
and 4 p.m., Monday through Friday. 
This notice contains information 
collection requirements that were 
submitted for review and approval to 
the Director of the Office of 
Management and Budget (OMB). The 
requirements were approved and 
assigned OMB control number 0910- 
0226. 
Dated: June 25, 1987. 
John M. Taylor, 
Associate Commissioner for Regulatory 
Affairs. 
[FR Doc. 87-14874 Filed 8-26-87; 11:07 am] 
BILUNG CODE 4160-01-M 
National Institutes of Health 
National Cancer Institute; Meeting 
Pursuant to Pub. L 92—163, notice is 
hereby given of the meeting of the NCI 
Thyroid/Iodine-131 Assessments 
Committee, Division of Cancer Etiology 
on August 24-25, 1987, Building 31, C 
YJ ing. Conference Room 7, National 
Institutes of Health, 9000 Rockville Pike, 
Bethesda, Maryland 20892. The meeting 
will be open to the public from 9 a.m. to 
recess on August 24 and from 9 a.m. to 
adjournment on August 25. Attendance 
by the public will be limited to space 
available. 
Mrs. Winifred Lumsden, Committee 
Management Officer, National Cancer 
Institute, Building 31, Room 10A06, 
National Institutes of Health, Bethesda, 
Maryland 20892 (301/496-5708) will 
provide summaries of the meeting and 
rosters of committee members, upon 
request. 
Dr. David McB. Howell, Executive 
Secretary of the NCI Thyroid/Iodine-131 
Assessments Committee. Division of 
Cancer Etiology, National Cancer 
Institute, Building 31, Room 11A06, 
National Institutes of Health, Bethesda, 
Maryland 20892 (301/496-6927) will 
furnish substantive program , 
information. 
Dated: June 24, 1987. 
Betty J. Beveridge, 
Committee Management Officer. NIH. 
|FR Doc. 87-14715 Filed 6-29-87; 8:45 amj 
BILLING CODE 4140-01-M 
Public Health Service 
National Institute of Environmental 
Health Sciences, Advisory Council on 
Hazardous Substances Research and 
Training Meeting 
Pursuant to Pub. L 92-163, notice is 
hereby given of a meeting to be held at 
the National Institutes of Health, 
National Library of Medicine. Director's 
Board Room (on the mezzanine), 
Building 38, Bethesda, Maryland, on July 
20, 1987. The meeting will begin at 9:00 
a.m. and end at approximately 4:30 p.m. 
The meeting is open to the public. 
The Superfund Amendments and 
Reauthorization Act of 1986 (SARA) 
established a university-based program 
of basic research and education within 
the NIEHS. The purpose of the meeting 
is to provide the Advisory Council on 
Hazardous Substances Research and 
Training the opportunity to review and 
comment upon the NIEHS plan and 
priorities for this program, which was 
previously described in the Federal 
Register of November 28, 1986 (51 FR 
43089-13092) and March 9, 1987 (52 FR 
7218-7223). The Council also is to aid in 
coordinating the NIEHS program with 
related programs of research, 
development, and demonstration 
conducted under other provisions of 
SARA. 
Topics to be discussed during the 
meeting may include but are not limited 
to: Overview of the NIEHS research 
program, NIEHS implementation plans, 
status of first-year grants, and research 
programs of other Federal agencies. 
Attendance is limited only by space 
available. For further information 
regarding the meeting, please contact 
Mr. Daniel C. VanderMeer, Executive 
Secretariat, NIEHS. P.O. Box 12233, 
Research Triangle Park, N.C. 27709 or 
telephone 919-541-3484 or FTS 629-3484. 
The official Government representative 
for this meeting will be Dr. Anne P. 
Sassaman. 
(Catalog of Federal Domestic Assistance 
Program No. 13.142, NIEHS Hazardous Waste 
Worker Health and Safety Training, NIH) 
Dated: June 24^1987. 
Betty J. Beveridgd, 
Committee Mana\ernent Officer. NIH. 
(FR Doc. 87-147lWiled 6-29-87; 8:45 am| 
BILUNG CODE 4140-G1-M 
Recombinant DNA Advisory 
Committee, Working Group on 
Revision on the NIH Guidelines; 
Meeting 
Pursuant to Pub. L 92-463. notice is 
hereby given of a meeting of the 
[ 12 ] 
Recombinant DNA Research, Volume 13 
